Table of Content



1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Peptide CDMO
1.2 Key Market Segments
1.2.1 Peptide CDMO Segment by Type
1.2.2 Peptide CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats

2 Peptide CDMO Market Overview
2.1 Global Market Overview
2.1.1 Global Peptide CDMO Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Peptide CDMO Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 Peptide CDMO Market Competitive Landscape
3.1 Global Peptide CDMO Sales by Manufacturers (2017-2022)
3.2 Global Peptide CDMO Revenue Market Share by Manufacturers (2017-2022)
3.3 Peptide CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Peptide CDMO Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Peptide CDMO Sales Sites, Area Served, Product Type
3.6 Peptide CDMO Market Competitive Situation and Trends
3.6.1 Peptide CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Peptide CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion

4 Peptide CDMO Industry Chain Analysis
4.1 Peptide CDMO Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 The Development and Dynamics of Peptide CDMO Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 Peptide CDMO Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peptide CDMO Sales Market Share by Type (2017-2022)
6.3 Global Peptide CDMO Market Size Market Share by Type (2017-2022)
6.4 Global Peptide CDMO Price by Type (2017-2022)

7 Peptide CDMO Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peptide CDMO Market Sales by Application (2017-2022)
7.3 Global Peptide CDMO Market Size (M USD) by Application (2017-2022)
7.4 Global Peptide CDMO Sales Growth Rate by Application (2017-2022)

8 Peptide CDMO Market Segmentation by Region
8.1 Global Peptide CDMO Sales by Region
8.1.1 Global Peptide CDMO Sales by Region
8.1.2 Global Peptide CDMO Sales Market Share by Region
8.2 North America
8.2.1 North America Peptide CDMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Peptide CDMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Peptide CDMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Peptide CDMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Peptide CDMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa

9 Key Companies Profiled
9.1 Bachem
9.1.1 Bachem Peptide CDMO Basic Information
9.1.2 Bachem Peptide CDMO Product Overview
9.1.3 Bachem Peptide CDMO Product Market Performance
9.1.4 Bachem Business Overview
9.1.5 Bachem Peptide CDMO SWOT Analysis
9.1.6 Bachem Recent Developments
9.2 PolyPeptide
9.2.1 PolyPeptide Peptide CDMO Basic Information
9.2.2 PolyPeptide Peptide CDMO Product Overview
9.2.3 PolyPeptide Peptide CDMO Product Market Performance
9.2.4 PolyPeptide Business Overview
9.2.5 PolyPeptide Peptide CDMO SWOT Analysis
9.2.6 PolyPeptide Recent Developments
9.3 AmbioPharm
9.3.1 AmbioPharm Peptide CDMO Basic Information
9.3.2 AmbioPharm Peptide CDMO Product Overview
9.3.3 AmbioPharm Peptide CDMO Product Market Performance
9.3.4 AmbioPharm Business Overview
9.3.5 AmbioPharm Peptide CDMO SWOT Analysis
9.3.6 AmbioPharm Recent Developments
9.4 USV Peptides
9.4.1 USV Peptides Peptide CDMO Basic Information
9.4.2 USV Peptides Peptide CDMO Product Overview
9.4.3 USV Peptides Peptide CDMO Product Market Performance
9.4.4 USV Peptides Business Overview
9.4.5 USV Peptides Peptide CDMO SWOT Analysis
9.4.6 USV Peptides Recent Developments
9.5 Thermo Fisher
9.5.1 Thermo Fisher Peptide CDMO Basic Information
9.5.2 Thermo Fisher Peptide CDMO Product Overview
9.5.3 Thermo Fisher Peptide CDMO Product Market Performance
9.5.4 Thermo Fisher Business Overview
9.5.5 Thermo Fisher Peptide CDMO SWOT Analysis
9.5.6 Thermo Fisher Recent Developments
9.6 Bio Basic
9.6.1 Bio Basic Peptide CDMO Basic Information
9.6.2 Bio Basic Peptide CDMO Product Overview
9.6.3 Bio Basic Peptide CDMO Product Market Performance
9.6.4 Bio Basic Business Overview
9.6.5 Bio Basic Recent Developments
9.7 JPT
9.7.1 JPT Peptide CDMO Basic Information
9.7.2 JPT Peptide CDMO Product Overview
9.7.3 JPT Peptide CDMO Product Market Performance
9.7.4 JPT Business Overview
9.7.5 JPT Recent Developments
9.8 Genscript
9.8.1 Genscript Peptide CDMO Basic Information
9.8.2 Genscript Peptide CDMO Product Overview
9.8.3 Genscript Peptide CDMO Product Market Performance
9.8.4 Genscript Business Overview
9.8.5 Genscript Recent Developments
9.9 Xinbang Pharma
9.9.1 Xinbang Pharma Peptide CDMO Basic Information
9.9.2 Xinbang Pharma Peptide CDMO Product Overview
9.9.3 Xinbang Pharma Peptide CDMO Product Market Performance
9.9.4 Xinbang Pharma Business Overview
9.9.5 Xinbang Pharma Recent Developments
9.10 ScinoPharm
9.10.1 ScinoPharm Peptide CDMO Basic Information
9.10.2 ScinoPharm Peptide CDMO Product Overview
9.10.3 ScinoPharm Peptide CDMO Product Market Performance
9.10.4 ScinoPharm Business Overview
9.10.5 ScinoPharm Recent Developments
9.11 SN Biopharm
9.11.1 SN Biopharm Peptide CDMO Basic Information
9.11.2 SN Biopharm Peptide CDMO Product Overview
9.11.3 SN Biopharm Peptide CDMO Product Market Performance
9.11.4 SN Biopharm Business Overview
9.11.5 SN Biopharm Recent Developments
9.12 CBL
9.12.1 CBL Peptide CDMO Basic Information
9.12.2 CBL Peptide CDMO Product Overview
9.12.3 CBL Peptide CDMO Product Market Performance
9.12.4 CBL Business Overview
9.12.5 CBL Recent Developments
9.13 Piramal Pharma
9.13.1 Piramal Pharma Peptide CDMO Basic Information
9.13.2 Piramal Pharma Peptide CDMO Product Overview
9.13.3 Piramal Pharma Peptide CDMO Product Market Performance
9.13.4 Piramal Pharma Business Overview
9.13.5 Piramal Pharma Recent Developments
9.14 CordenPharma
9.14.1 CordenPharma Peptide CDMO Basic Information
9.14.2 CordenPharma Peptide CDMO Product Overview
9.14.3 CordenPharma Peptide CDMO Product Market Performance
9.14.4 CordenPharma Business Overview
9.14.5 CordenPharma Recent Developments
9.15 CPC Scientific
9.15.1 CPC Scientific Peptide CDMO Basic Information
9.15.2 CPC Scientific Peptide CDMO Product Overview
9.15.3 CPC Scientific Peptide CDMO Product Market Performance
9.15.4 CPC Scientific Business Overview
9.15.5 CPC Scientific Recent Developments
10 Peptide CDMO Market Forecast by Region
10.1 Global Peptide CDMO Market Size Forecast
10.2 Global Peptide CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Peptide CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Peptide CDMO Market Size Forecast by Region
10.2.4 South America Peptide CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Peptide CDMO by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Peptide CDMO Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Peptide CDMO by Type (2022-2028)
11.1.2 Global Peptide CDMO Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Peptide CDMO by Type (2022-2028)
11.2 Global Peptide CDMO Market Forecast by Application (2022-2028)
11.2.1 Global Peptide CDMO Sales (K Units) Forecast by Application
11.2.2 Global Peptide CDMO Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings



List of Figures

?LIST OF TABLES

Table 1. Introduction of the Type

Table 2. Introduction of the Application

Table 3. Market Size (M USD) Segment Executive Summary

Table 4. Peptide CDMO Market Size (M USD) Comparison by Region (M USD)

Table 5. Global Peptide CDMO Sales (K Units) by Manufacturers (2017-2022)

Table 6. Global Peptide CDMO Sales Market Share by Manufacturers (2017-2022)

Table 7. Global Peptide CDMO Revenue (M USD) by Manufacturers (2017-2022)

Table 8. Global Peptide CDMO Revenue Share by Manufacturers (2017-2022)

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide CDMO as of 2021)

Table 10. Global Market Peptide CDMO Average Price (USD/Unit) of Key Manufacturers (2017-2022)

Table 11. Manufacturers Peptide CDMO Sales Sites and Area Served

Table 12. Manufacturers Peptide CDMO Product Type

Table 13. Global Peptide CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Mergers & Acquisitions, Expansion Plans

Table 15. Industry Chain Map of Peptide CDMO

Table 16. Raw Materials

Table 17. Midstream Market Analysis

Table 18. Downstream Customer Analysis

Table 19. Key Development Trends

Table 20. Driving Factors

Table 21. Peptide CDMO Market Challenges

Table 22. Market Restraints

Table 23. Global Peptide CDMO Sales by Type (K Units)

Table 24. Global Peptide CDMO Market Size by Type (M USD)

Table 25. Global Peptide CDMO Sales (K Units) by Type (2017-2022)

Table 26. Global Peptide CDMO Sales Market Share by Type (2017-2022)

Table 27. Global Peptide CDMO Market Size (M USD) by Type (2017-2022)

Table 28. Global Peptide CDMO Market Size Share by Type (2017-2022)

Table 29. Global Peptide CDMO Price (USD/Unit) by Type (2017-2022)

Table 30. Global Peptide CDMO Sales (K Units) by Application

Table 31. Global Peptide CDMO Market Size by Application

Table 32. Global Peptide CDMO Sales by Application (2017-2022) & (K Units)

Table 33. Global Peptide CDMO Sales Market Share by Application (2017-2022)

Table 34. Global Peptide CDMO Sales by Application (2017-2022) & (M USD)

Table 35. Global Peptide CDMO Market Share by Application (2017-2022)

Table 36. Global Peptide CDMO Sales Growth Rate by Application (2017-2022)

Table 37. Global Peptide CDMO Sales by Region (2017-2022) & (K Units)

Table 38. Global Peptide CDMO Sales Market Share by Region (2017-2022)

Table 39. North America Peptide CDMO Sales by Country (2017-2022) & (K Units)

Table 40. Europe Peptide CDMO Sales by Country (2017-2022) & (K Units)

Table 41. Asia Pacific Peptide CDMO Sales by Region (2017-2022) & (K Units)

Table 42. South America Peptide CDMO Sales by Country (2017-2022) & (K Units)

Table 43. Middle East and Africa Peptide CDMO Sales by Region (2017-2022) & (K Units)

Table 44. Bachem Peptide CDMO Basic Information

Table 45. Bachem Peptide CDMO Product Overview

Table 46. Bachem Peptide CDMO Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 47. Bachem Business Overview

Table 48. Bachem Peptide CDMO SWOT Analysis

Table 49. Bachem Recent Developments

Table 50. PolyPeptide Peptide CDMO Basic Information

Table 51. PolyPeptide Peptide CDMO Product Overview

Table 52. PolyPeptide Peptide CDMO Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 53. PolyPeptide Business Overview

Table 54. PolyPeptide Peptide CDMO SWOT Analysis

Table 55. PolyPeptide Recent Developments

Table 56. AmbioPharm Peptide CDMO Basic Information

Table 57. AmbioPharm Peptide CDMO Product Overview

Table 58. AmbioPharm Peptide CDMO Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 59. AmbioPharm Business Overview

Table 60. AmbioPharm Peptide CDMO SWOT Analysis

Table 61. AmbioPharm Recent Developments

Table 62. USV Peptides Peptide CDMO Basic Information

Table 63. USV Peptides Peptide CDMO Product Overview

Table 64. USV Peptides Peptide CDMO Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 65. USV Peptides Business Overview

Table 66. USV Peptides Peptide CDMO SWOT Analysis

Table 67. USV Peptides Recent Developments

Table 68. Thermo Fisher Peptide CDMO Basic Information

Table 69. Thermo Fisher Peptide CDMO Product Overview

Table 70. Thermo Fisher Peptide CDMO Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 71. Thermo Fisher Business Overview

Table 72. Thermo Fisher Peptide CDMO SWOT Analysis

Table 73. Thermo Fisher Recent Developments

Table 74. Bio Basic Peptide CDMO Basic Information

Table 75. Bio Basic Peptide CDMO Product Overview

Table 76. Bio Basic Peptide CDMO Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 77. Bio Basic Business Overview

Table 78. Bio Basic Recent Developments

Table 79. JPT Peptide CDMO Basic Information

Table 80. JPT Peptide CDMO Product Overview

Table 81. JPT Peptide CDMO Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 82. JPT Business Overview

Table 83. JPT Recent Developments

Table 84. Genscript Peptide CDMO Basic Information

Table 85. Genscript Peptide CDMO Product Overview

Table 86. Genscript Peptide CDMO Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 87. Genscript Business Overview

Table 88. Genscript Recent Developments

Table 89. Xinbang Pharma Peptide CDMO Basic Information

Table 90. Xinbang Pharma Peptide CDMO Product Overview

Table 91. Xinbang Pharma Peptide CDMO Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 92. Xinbang Pharma Business Overview

Table 93. Xinbang Pharma Recent Developments

Table 94. ScinoPharm Peptide CDMO Basic Information

Table 95. ScinoPharm Peptide CDMO Product Overview

Table 96. ScinoPharm Peptide CDMO Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 97. ScinoPharm Business Overview

Table 98. ScinoPharm Recent Developments

Table 99. SN Biopharm Peptide CDMO Basic Information

Table 100. SN Biopharm Peptide CDMO Product Overview

Table 101. SN Biopharm Peptide CDMO Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 102. SN Biopharm Business Overview

Table 103. SN Biopharm Recent Developments

Table 104. CBL Peptide CDMO Basic Information

Table 105. CBL Peptide CDMO Product Overview

Table 106. CBL Peptide CDMO Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 107. CBL Business Overview

Table 108. CBL Recent Developments

Table 109. Piramal Pharma Peptide CDMO Basic Information

Table 110. Piramal Pharma Peptide CDMO Product Overview

Table 111. Piramal Pharma Peptide CDMO Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 112. Piramal Pharma Business Overview

Table 113. Piramal Pharma Recent Developments

Table 114. CordenPharma Peptide CDMO Basic Information

Table 115. CordenPharma Peptide CDMO Product Overview

Table 116. CordenPharma Peptide CDMO Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 117. CordenPharma Business Overview

Table 118. CordenPharma Recent Developments

Table 119. CPC Scientific Peptide CDMO Basic Information

Table 120. CPC Scientific Peptide CDMO Product Overview

Table 121. CPC Scientific Peptide CDMO Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin

(2017-2022)

Table 122. CPC Scientific Business Overview

Table 123. CPC Scientific Recent Developments

Table 124. Global Peptide CDMO Sales Forecast by Region (K Units)

Table 125. Global Peptide CDMO Market Size Forecast by Region (M USD)

Table 126. North America Peptide CDMO Sales Forecast by Country (2022-2028) & (K Units)

Table 127. North America Peptide CDMO Market Size Forecast by Country (2022-2028) & (M USD)

Table 128. Europe Peptide CDMO Sales Forecast by Country (2022-2028) & (K Units)

Table 129. Europe Peptide CDMO Market Size Forecast by Country (2022-2028) & (M USD)

Table 130. Asia Pacific Peptide CDMO Sales Forecast by Region (2022-2028) & (K Units)

Table 131. Asia Pacific Peptide CDMO Market Size Forecast by Region (2022-2028) & (M USD)

Table 132. South America Peptide CDMO Sales Forecast by Country (2022-2028) & (K Units)

Table 133. South America Peptide CDMO Market Size Forecast by Country (2022-2028) & (M USD)

Table 134. Middle East and Africa Peptide CDMO Consumption Forecast by Country (2022-2028) & (Units)

Table 135. Middle East and Africa Peptide CDMO Market Size Forecast by Country (2022-2028) & (M USD)

Table 136. Global Peptide CDMO Sales Forecast by Type (2022-2028) & (K Units)

Table 137. Global Peptide CDMO Market Size Forecast by Type (2022-2028) & (M USD)

Table 138. Global Peptide CDMO Price Forecast by Type (2022-2028) & (USD/Unit)

Table 139. Global Peptide CDMO Sales (K Units) Forecast by Application (2022-2028)

Table 140. Global Peptide CDMO Market Size Forecast by Application (2022-2028) & (M USD)

List of Figures

Figure 1. Product Picture of Peptide CDMO

Figure 2. Data Triangulation

Figure 3. Key Caveats

Figure 4. Global Peptide CDMO Market Size (M USD), 2017-2028

Figure 5. Global Peptide CDMO Market Size (M USD) (2017-2028)

Figure 6. Global Peptide CDMO Sales (K Units) & (2017-2028)

Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)

Figure 9. Evaluation Matrix of Regional Market Development Potential

Figure 10. Peptide CDMO Market Size (M USD) by Country (M USD)

Figure 11. Peptide CDMO Sales Share by Manufacturers in 2020

Figure 12. Global Peptide CDMO Revenue Share by Manufacturers in 2020

Figure 13. Peptide CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

Figure 14. Global Market Peptide CDMO Average Price (USD/Unit) of Key Manufacturers in 2020

Figure 15. The Global 5 and 10 Largest Players: Market Share by Peptide CDMO Revenue in 2021

Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 17. Global Peptide CDMO Market Share by Type

Figure 18. Sales Market Share of Peptide CDMO by Type (2017-2022)

Figure 19. Sales Market Share of Peptide CDMO by Type in 2021

Figure 20. Market Size Share of Peptide CDMO by Type (2017-2022)

Figure 21. Market Size Market Share of Peptide CDMO by Type in 2020

Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)

Figure 23. Global Peptide CDMO Market Share by Application

Figure 24. Global Peptide CDMO Sales Market Share by Application (2017-2022)

Figure 25. Global Peptide CDMO Sales Market Share by Application in 2021

Figure 26. Global Peptide CDMO Market Share by Application (2017-2022)

Figure 27. Global Peptide CDMO Market Share by Application in 2020

Figure 28. Global Peptide CDMO Sales Growth Rate by Application (2017-2022)

Figure 29. Global Peptide CDMO Sales Market Share by Region (2017-2022)

Figure 30. North America Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 31. North America Peptide CDMO Sales Market Share by Country in 2020

Figure 32. U.S. Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 33. Canada Peptide CDMO Sales (K Units) and Growth Rate (2017-2022)

Figure 34. Mexico Peptide CDMO Sales (Units) and Growth Rate (2017-2022)

Figure 35. Europe Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 36. Europe Peptide CDMO Sales Market Share by Country in 2020

Figure 37. Germany Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 38. France Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 39. U.K. Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 40. Italy Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 41. Russia Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 42. Asia Pacific Peptide CDMO Sales and Growth Rate (K Units)

Figure 43. Asia Pacific Peptide CDMO Sales Market Share by Region in 2020

Figure 44. China Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 45. Japan Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 46. South Korea Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 47. India Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 48. Southeast Asia Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 49. South America Peptide CDMO Sales and Growth Rate (K Units)

Figure 50. South America Peptide CDMO Sales Market Share by Country in 2020

Figure 51. Brazil Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 52. Argentina Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 53. Columbia Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 54. Middle East and Africa Peptide CDMO Sales and Growth Rate (K Units)

Figure 55. Middle East and Africa Peptide CDMO Sales Market Share by Region in 2020

Figure 56. Saudi Arabia Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 57. UAE Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 58. Egypt Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 59. Nigeria Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 60. South Africa Peptide CDMO Sales and Growth Rate (2017-2022) & (K Units)

Figure 61. Global Peptide CDMO Sales Forecast by Volume (2017-2028) & (K Units)

Figure 62. Global Peptide CDMO Market Size Forecast by Value (2017-2028) & (M USD)

Figure 63. Global Peptide CDMO Sales Market Share Forecast by Type (2022-2028)

Figure 64. Global Peptide CDMO Market Share Forecast by Type (2022-2028)

Figure 65. Global Peptide CDMO Sales Forecast by Application (2022-2028)

Figure 66. Global Peptide CDMO Market Share Forecast by Application (2022-2028)